| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1050606036 |
| P356 | DOI | 10.1186/S13075-016-1158-Z |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/s13075-016-1158-z |
| P932 | PMC publication ID | 5112667 |
| P698 | PubMed publication ID | 27852285 |
| P2093 | author name string | Jie Wang | |
| Juan Du | |||
| Jinhua Xu | |||
| Yilun Wang | |||
| Yan Ge | |||
| Jun Liang | |||
| Haihong Qin | |||
| Xiaohua Zhu | |||
| Jinran Lin | |||
| P2860 | cites work | Identification of unique microRNA signature associated with lupus nephritis | Q21136392 |
| MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation | Q24628741 | ||
| Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus | Q28088753 | ||
| Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
| Regulatory T cells and immune tolerance | Q29616864 | ||
| Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. | Q33377575 | ||
| IFN priming is necessary but not sufficient to turn on a migratory dendritic cell program in lupus monocytes | Q33788323 | ||
| Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression | Q34118755 | ||
| Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes | Q71727781 | ||
| IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25+ T cell regulatory functions | Q79445141 | ||
| Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus | Q80060123 | ||
| miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells | Q34138772 | ||
| Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus | Q34230520 | ||
| Sex Differences in monocytes and TLR4 associated immune responses; implications for systemic lupus erythematosus (SLE) | Q34323715 | ||
| Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage | Q34443260 | ||
| Clearance deficiency and systemic lupus erythematosus (SLE). | Q34609705 | ||
| Altered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome. | Q34669630 | ||
| miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. | Q34923751 | ||
| Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. | Q35636786 | ||
| miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program | Q36145947 | ||
| Gene expression profile reveals abnormalities of multiple signaling pathways in mesenchymal stem cell derived from patients with systemic lupus erythematosus | Q36206615 | ||
| Tolerogenic versus inflammatory activity of peripheral blood monocytes and dendritic cells subpopulations in systemic lupus erythematosus | Q36219637 | ||
| Discovery of a novel genetic susceptibility locus on X chromosome for systemic lupus erythematosus | Q36346648 | ||
| Regulation of dendritic cell activation by microRNA let-7c and BLIMP1 | Q36580382 | ||
| miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA. | Q37087212 | ||
| Epigenetic mechanisms in lupus | Q37284401 | ||
| Gender and age influence on clinical and laboratory features in Chinese patients with systemic lupus erythematosus: 1,790 cases | Q37585137 | ||
| The role of dendritic cells in the pathogenesis of systemic lupus erythematosus | Q37737799 | ||
| Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus. | Q38002644 | ||
| PPARγ inhibits HMGB1 expression through upregulation of miR-142-3p in vitro and in vivo. | Q38294525 | ||
| MiR-142-3p controls the specification of definitive hemangioblasts during ontogeny. | Q38313689 | ||
| miR-142-3p prevents macrophage differentiation during cancer-induced myelopoiesis | Q39133794 | ||
| Silencing of c-Fos expression by microRNA-155 is critical for dendritic cell maturation and function. | Q39579366 | ||
| Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice | Q40634158 | ||
| Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity | Q41486353 | ||
| Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17. | Q41937849 | ||
| Altered lymphopoiesis and immunodeficiency in miR-142 null mice. | Q42144783 | ||
| Immune complexes inhibit differentiation, maturation, and function of human monocyte-derived dendritic cells. | Q42514349 | ||
| Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies | Q43584277 | ||
| Mononuclear phagocyte miRNome analysis identifies miR-142 as critical regulator of murine dendritic cell homeostasis | Q43603753 | ||
| Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis | Q44688981 | ||
| Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs. | Q45152333 | ||
| The role of serum IL-17 and IL-6 as biomarkers of disease activity and predictors of remission in patients with lupus nephritis | Q46888202 | ||
| Differentiation of human dendritic cells from monocytes in vitro. | Q51106538 | ||
| Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. | Q53592228 | ||
| Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. | Q53718320 | ||
| Circulating microRNA expression profiles associated with systemic lupus erythematosus. | Q54272397 | ||
| Possible role of the JAK/STAT pathways in the regulation of T cell-interferon related genes in systemic lupus erythematosus. | Q54344883 | ||
| Functional characterization of peripheral blood dendritic cells and monocytes in systemic lupus erythematosus | Q60724747 | ||
| Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus | Q61050853 | ||
| The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation | Q61645724 | ||
| P433 | issue | 1 | |
| P921 | main subject | dendritic cell | Q506253 |
| inflammation | Q101991 | ||
| P304 | page(s) | 263 | |
| P577 | publication date | 2016-11-16 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | Elevated expression of miR-142-3p is related to the pro-inflammatory function of monocyte-derived dendritic cells in SLE. | |
| P478 | volume | 18 |
| Q92405066 | Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies |
| Q93149071 | Biologic Mechanisms Linked to Prognosis in Ovarian Cancer that May Be Affected by Aging |
| Q49966463 | Diagnostic and prognostic tests in systemic lupus erythematosus. |
| Q39456337 | Epigenetic involvement in etiopathogenesis and implications in treatment of systemic lupus erythematous |
| Q92276926 | Integrated analysis of lncRNA, miRNA and mRNA expression profiling in patients with systemic lupus erythematosus |
| Q55620756 | Long noncoding RNA expression profile and association with SLEDAI score in monocyte-derived dendritic cells from patients with systematic lupus erythematosus. |
| Q57471217 | MicroRNAs in Autoimmunity and Hematological Malignancies |
| Q89041968 | Muscle miRNAome shows suppression of chronic inflammatory miRNAs with both prednisone and vamorolone |
| Q59359538 | Plasma miRNA-122-5p and miRNA-151a-3p identified as potential biomarkers for liver injury among CHB patients with PNALT |
| Q55307073 | Presymptomatic change in microRNAs modulates Tau pathology. |
| Q89783319 | Role of microRNAs in the Regulation of Dendritic Cell Generation and Function |
| Q55012595 | The Involvement of MicroRNAs in Modulation of Innate and Adaptive Immunity in Systemic Lupus Erythematosus and Lupus Nephritis. |
| Q92579594 | The function of ncRNAs in rheumatic diseases |
| Q61443682 | The mechanism of miR-142-3p in coronary microembolization-induced myocardiac injury via regulating target gene IRAK-1 |
| Q41228881 | Translating epigenetics into clinic: focus on lupus |
Search more.